Infectious disease testing platforms.

Ended Awarded Last action

Contract number
HT001424F0022
Awardee
Awarding agency
Obligated
$237,294

Award facts

Contract value 100% obligated
$237,293.66 Current and potential, with all options
Completion date
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $237,294

About this award

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, by the Defense Health Agency (DHA). The $237,293.66 contract is for the delivery of infectious disease testing platforms, with an ultimate completion date of December 15, 2023. Roche Diagnostics has provided similar laboratory equipment, reagents, and services to various federal agencies under GSA Schedule contracts and other indefinite delivery vehicles. This award does not have a set-aside designation.

Quick answers

Who was awarded contract HT001424F0022?

HT001424F0022 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on December 15, 2023.

How much is contract HT001424F0022 worth?

The government has obligated $237,294 on HT001424F0022.

Is contract HT001424F0022 an order under another contract?

Yes. HT001424F0022 is a BPA call under HT001421A0001, a blanket purchase agreement.

Was contract HT001424F0022 competed?

The extent of competition for HT001424F0022 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award